Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07826949) titled 'A Phase 1 Study of SRN-101 Administered Prior to Surgical Resection in Adults With Recurrent High-Grade Glioma' on Sept. 10.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Sequential Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Nicholas Butowski
Condition:
Recurrent High-Grade Gliomas
Brain Neoplasm
Glioma
Intervention:
Drug: SRN-101
Procedure: Blood Specimen Collection
Procedure: Surgical Resection
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: October 15, 2026
Target Sample Size: 6
Countrie...